Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of preeclampsia in oocyte donation pregnancies with early aspirin
2011-005979-16Phase 3Terminated
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in preeclampsia, pregnancy-induced hypertension (PIH) and intrauterine growth restriction (IUGR), sponsored by Health Research Institute Hospital La Fe. Primary endpoints: Occurrence of preeclampsia, Development of gestational hypertension and 2 more. Started Sep 2012; status: terminated.
02
Drugs
aspirin
03
Conditions
preeclampsiapregnancy-induced hypertension (PIH)intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2011-005979-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005979-16.